TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Clinical trial NCT02693535 · RECRUITING
Trial details
- NCT number
- NCT02693535
- Sponsor
- American Society of Clinical Oncology
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-14
- Primary completion
- 2027-12-31
- Enrollment
- 4200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.